An infant diagnosed with Spinal Muscular Atrophy at five weeks received crucial early treatment from doctors. This early diagnosis allowed for immediate initiation of gene replacement therapy at seven months. The expensive nature of gene therapy required the family to seek crowdfunding support for the treatment. Timely intervention is essential to preserve motor neuron function and enhance development in infants.
